Efficacy of a Relaxation Scenario in Virtual Reality for the Comorbid Symptoms of Anxiety and Asthenia in a General Hospital Setting: A Pilot Comparative Randomized Open-Label Study

Abstract

BACKGROUND: Patients in general hospitals often display concomitant signs of mental maladjustment: low mood, anxiety, apathy, asthenia, all of which can have a negative impact on the course of the underlying disease and the recovery process. One of the non-pharmacological approaches that has gained wider acceptance in medical practice in recent years is the use of procedures based on virtual reality.

AIM: Assess the efficacy of the new domestic, virtual reality application Flow as relates to symptoms of anxiety and asthenia in patients undergoing inpatient treatment.

METHODS: The study was open-label and had a comparison group; the patients were assigned to the experimental or control group using a randomization table. The patients were assessed using the Spielberger State Anxiety Inventory; the Fatigue Symptom Rating Scale; the Well-being, Activity, Mood questionnaire; the Depression Anxiety Stress Scale; and the Clinical Global Impression Scale. Physical parameters were measured before and after each virtual reality session. The obtained data were statistically processed.

RESULTS: The study involved 60 patients. In 40 patients, the treatment program included a course of five daily relaxation sessions in virtual reality; the control group consisted of 20 patients, who were treated in accordance with the usual practice of the institution. The addition of virtual reality sessions to the standard treatment course yielded significant advantage in terms of affective symptoms reduction in patients both after a single session and as a result of undergoing the full course, and several days after its completion. The patients in the experimental group also showed a significant decrease in blood pressure after the sessions, and this was most pronounced in individuals who initially had elevated and high blood pressure.

CONCLUSION: The use of relaxation program courses in the virtual reality application Flow is an effective and promising means of non-pharmacological care for non-psychiatric inpatients showing symptoms of anxiety, apathy, depressive mood, as well as hypertension.

Keywords

virtual reality / non-pharmacological therapy / comorbid mental symptoms / maladjustment reaction / lowering blood pressure

References

[1] Medeiros GC, Roy D, Kontos N, Beach SR. Post-stroke depression: a 2020 updated review. Gen Hosp Psychiatry. 2020;66:70-80. doi: 10.1016/j.genhosppsych.2020.06.011.

[2] Walker J, van Niekerk M, Hobbs H, et al. The prevalence of anxiety in general hospital inpatients: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2021;72:131-40. doi: 10.1016/j.genhosppsych.2021.08.004.

[3] Janeczek P. Coexistence of mental and somatic diseases and difficulties in diagnosis and working with mentally ill people. J Educ Health Sport. 2022;12(7):649-59. doi: 10.12775/JEHS.2022.12.07.065.

[4] Sikter A. Hypocapnia and mental stress can trigger vicious circles in critically ill patients due to energy imbalance: a hypothesis presented through cardiogenic pulmonary oedema. Neuropsychopharmacol Hung. 2018;20(2):65-74.

[5] DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-7. doi: 10.1001/archinte.160.14.2101.

[6] Sobel RM, Markov D. The impact of anxiety and mood disorders on physical disease: the worried not-so-well. Curr Psychiatry Rep. 2005;7(3):206-12. doi: 10.1007/s11920-005-0055-y.

[7] Johnson HM. Anxiety and hypertension: is there a link? A literature review of the comorbidity relationship between anxiety and hypertension. Curr Hypertens Rep. 2019;21(9):66. doi: 10.1007/s11906-019-0972-5.

[8] Michelini S, Cassano GB, Frare F, Perugi G. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry. 1996;29(4):127-34. doi: 10.1055/s-2007-979558.

[9] Jain S, Shapiro SL, Swanick S, et al. A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med. 2007;33(1):11-21. doi: 10.1207/s15324796abm3301_2.

[10] Barrett CJ. Mindfulness and rehabilitation: teaching yoga and meditation to young men in an alternative to incarceration program. Int J Offender Ther Comp Criminol. 2017;61(15):1719-38. doi: 10.1177/0306624X16633667.

[11] Amarasekera AT, Chang D. Buddhist meditation for vascular function: a narrative review. Integr Med Res. 2019;8(4):252-6. doi: 10.1016/j.imr.2019.11.002.

[12] Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens. 2008;21(3):310-6. doi: 10.1038/ajh.2007.65.

[13] Geiger C, Cramer H, Dobos G, Kohl-Heckl WK. A systematic review and meta-analysis of mindfulness-based stress reduction for arterial hypertension. J Hum Hypertens. 2022. doi: 10.1038/s41371-022-00764-z.

[14] Prakhinkit S, Suppapitiporn S, Tanaka H, Suksom D. Effects of Buddhism walking meditation on depression, functional fitness, and endothelium-dependent vasodilation in depressed elderly. J Altern Complement Med. 2014;20(5):411-6. doi: 10.1089/acm.2013.0205.

[15] Pascoe MC, Thompson DR, Jenkins ZM, Ski CF. Mindfulness mediates the physiological markers of stress: systematic review and meta-analysis. J Psychiatr Res. 2017;95:156-78. doi: 10.1016/j.jpsychires.2017.08.004.

[16] Ponte Márquez PH, Feliu-Soler A, Solé-Villa MJ, et al. Benefits of mindfulness meditation in reducing blood pressure and stress in patients with arterial hypertension. J Hum Hypertens. 2019;33(3):237-47. doi: 10.1038/s41371-018-0130-6.

[17] Shi L, Zhang D, Wang L, et al. Meditation and blood pressure: a meta-analysis of randomized clinical trials. J Hypertens. 2017;35(4):696-706. doi: 10.1097/HJH.0000000000001217.

[18] Barnes VA, Pendergrast RA, Harshfield GA, Treiber FA. Impact of breathing awareness meditation on ambulatory blood pressure and sodium handling in prehypertensive African American adolescents. Ethn Dis. 2008;18(1):1-5.

[19] Adams ZW, Sieverdes JC, Brunner-Jackson B, et al. Meditation smartphone application effects on prehypertensive adults’ blood pressure: dose-response feasibility trial. Health Psychol. 2018;37(9):850-60. doi: 10.1037/hea0000584.

[20] Liaw SY, Choo T, Wu LT, et al. “Wow, woo, win” — healthcare students’ and facilitators’ experiences of interprofessional simulation in three-dimensional virtual world: a qualitative evaluation study. Nurse Educ Today. 2021;105:105018. doi: 10.1016/j.nedt.2021.105018.

[21] Zhang M, Ding H, Naumceska M, Zhang Y. Virtual reality technology as an educational and intervention tool for children with autism spectrum disorder: current perspectives and future directions. Behav Sci (Basel). 2022;12(5):138. doi: 10.3390/bs12050138.

[22] Taneja A, Vishal SB, Mahesh V, Geethanjali B. Virtual reality based neuro-rehabilitation for mental stress reduction. In: 2017 fourth international conference on signal processing, communication and networking (ICSCN); 2017 March 16-18; Chennai, India. IEEE; 2017. p. 1-5. doi: 10.1109/ICSCN.2017.8085665.

[23] Georgiev DD, Georgieva I, Gong Z, et al. Virtual reality for neurorehabilitation and cognitive enhancement. Brain Sci. 2021;11(2):221. doi: 10.3390/brainsci11020221.

[24] Carl E, Stein AT, Levihn-Coon A, et al. Virtual reality exposure therapy for anxiety and related disorders: a meta-analysis of randomized controlled trials. J Anxiety Disord. 2019;61:27-36. doi: 10.1016/j.janxdis.2018.08.003.

[25] Wechsler TF, Kümpers F, Mühlberger A. Inferiority or even superiority of virtual reality exposure therapy in phobias? — A systematic review and quantitative meta-analysis on randomized controlled trials specifically comparing the efficacy of virtual reality exposure to gold standard in vivo exposure in agoraphobia, specific phobia, and social phobia. Front Psychol. 2019;10:1758. doi: 10.3389/fpsyg.2019.01758.

[26] Clus D, Larsen ME, Lemey C, Berrouiguet S. The use of virtual reality in patients with eating disorders: systematic review. J Med Internet Res. 2018;20(4):e157. doi: 10.2196/jmir.7898.

[27] Khanin YuL. Kratkoe rukovodstvo k shkale reaktivnoi i lichnostnoi trevozhnosti Ch.D. Spilbergera. Leningrad: LNIIFK; 1976. 40 p. Russian.

[28] Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Qual Life Res. 2002;11(3):263-72. doi: 10.1023/a:1015295106602.

[29] Burlachuk LF, Morozov SM. Slovar’-spravochnik po psikhodiagnostike. 2nd ed. Saint Petersburg: Piter; 2003. 528 p. Russian.

[30] Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. 2nd ed. Sydney: Psychology Foundation of Australia; 1995. 42 p.

[31] Guy W. ECDEU assessment manual for psychopharmacology. Rockville: US department of health and human services, public health service, alcohol drug abuse and mental health administration, NIMH, psychopharmacology research branch; 1976. 028 Clinical global impressions (CGI); p. 218-22.

[32] Donnelly MR, Reinberg R, Ito KL, et al. Virtual reality for the treatment of anxiety disorders: a scoping review. Am J Occup Ther. 2021;75(6):7506205040. doi: 10.5014/ajot.2021.046169.

[33] Smith V, Warty RR, Sursas JA, et al. The effectiveness of virtual reality in managing acute pain and anxiety for medical inpatients: systematic review. J Med Internet Res. 2020;22(11):e17980. doi: 10.2196/17980.

[34] Ridout B, Kelson J, Campbell A, Steinbeck K. Effectiveness of virtual reality interventions for adolescent patients in hospital settings: systematic review. J Med Internet Res. 2021;23(6):e24967. doi: 10.2196/24967.

[35] Saposnik G, Cohen LG, Mamdani M, et al.; Stroke outcomes research Canada. efficacy and safety of non-immersive virtual reality exercising in stroke rehabilitation (EVREST): a randomised, multicentre, single-blind, controlled trial. Lancet Neurol. 2016;15(10):1019-27. doi: 10.1016/S1474-4422(16)30121-1.

[36] Sarkar U, Lee JE, Nguyen KH, et al. Barriers and facilitators to the implementation of virtual reality as a pain management modality in academic, community, and safety-net settings: qualitative analysis. J Med Internet Res. 2021;23(9):e26623. doi: 10.2196/26623.

RIGHTS & PERMISSIONS

Lepilkina T.А., Beniashvili A.G., Cheremin R.A., Malyukova N.G., Morozova M.A., Bogdanov M.A., Burminsky D.S., Potanin S.S., Rodkina S.V., Rupchev G.E., Eip M.N.